Download presentation
Presentation is loading. Please wait.
Published byRodney Jennings Modified over 6 years ago
1
Figure 1. GID SVF-1 device (Louisville, CO) with concentrated cell pellet.
From: Adipose Derived Stromal Cell (ADSC) Injections for Pain Management of Osteoarthritis in the Human Knee Joint Aesthet Surg J. 2015;36(2): doi: /asj/sjv135 Aesthet Surg J | © 2015 The American Society for Aesthetic Plastic Surgery, Inc. Reprints and permission:
2
Figure 2. Preoperative, 3-month postoperative, and 1-year postoperative WOMAC Scores.
From: Adipose Derived Stromal Cell (ADSC) Injections for Pain Management of Osteoarthritis in the Human Knee Joint Aesthet Surg J. 2015;36(2): doi: /asj/sjv135 Aesthet Surg J | © 2015 The American Society for Aesthetic Plastic Surgery, Inc. Reprints and permission:
3
Figure 3. Preoperative, 3-month postoperative, and 1-year postoperative VAS Scores.
From: Adipose Derived Stromal Cell (ADSC) Injections for Pain Management of Osteoarthritis in the Human Knee Joint Aesthet Surg J. 2015;36(2): doi: /asj/sjv135 Aesthet Surg J | © 2015 The American Society for Aesthetic Plastic Surgery, Inc. Reprints and permission:
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.